American Overdose: The Opioid Tragedy in Three Acts

by Chris McGreal

Yet ultimately, Wright did approve OxyContin for wide use. He deemed it an appropriate remedy for moderate to severe pain—a departure from the FDA’s usual practice. Shortly afterward he left the FDA. Within two years he was working at Purdue.